![]() |
Name |
multiplolide A
|
Molecular Formula | C10H14O5 | |
IUPAC Name* |
(1S,4R,6R,7S,8E,10S)-6,7-dihydroxy-4-methyl-3,11-dioxabicyclo[8.1.0]undec-8-en-2-one
|
|
SMILES |
C[C@@H]1C[C@H]([C@H](/C=C/[C@H]2[C@H](O2)C(=O)O1)O)O
|
|
InChI |
InChI=1S/C10H14O5/c1-5-4-7(12)6(11)2-3-8-9(15-8)10(13)14-5/h2-3,5-9,11-12H,4H2,1H3/b3-2+/t5-,6+,7-,8+,9+/m1/s1
|
|
InChIKey |
GSXXKILAEILYRX-JRSSMJHLSA-N
|
|
Synonyms |
multiplolide A; CHEBI:66411; (1S,4R,6R,7S,8E,10S)-6,7-dihydroxy-4-methyl-3,11-dioxabicyclo[8.1.0]undec-8-en-2-one; (1S,2E,4S,5R,7R,10S)-4,5-dihydroxy-7-methyl-8,11-dioxabicyclo[8.1.0]undec-2-en-9-one; CHEMBL466333; DTXSID701125030; 356043-22-6; Q27134968; D-glycero-D-manno-Dec-4-enonic acid, 2,3-anhydro-4,5,8,10-tetradeoxy-, theta;-lactone, (4E)-
|
|
CAS | 356043-22-6 | |
PubChem CID | 24879663 | |
ChEMBL ID | CHEMBL466333 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 214.21 | ALogp: | -0.4 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 79.3 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.332 |
Caco-2 Permeability: | -5.161 | MDCK Permeability: | 0.00008700 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.022 |
Human Intestinal Absorption (HIA): | 0.494 | 20% Bioavailability (F20%): | 0.064 |
30% Bioavailability (F30%): | 0.996 |
Blood-Brain-Barrier Penetration (BBB): | 0.833 | Plasma Protein Binding (PPB): | 68.65% |
Volume Distribution (VD): | 1.139 | Fu: | 32.96% |
CYP1A2-inhibitor: | 0.036 | CYP1A2-substrate: | 0.072 |
CYP2C19-inhibitor: | 0.032 | CYP2C19-substrate: | 0.475 |
CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.232 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.303 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.147 |
Clearance (CL): | 2.659 | Half-life (T1/2): | 0.603 |
hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.377 |
Drug-inuced Liver Injury (DILI): | 0.899 | AMES Toxicity: | 0.236 |
Rat Oral Acute Toxicity: | 0.372 | Maximum Recommended Daily Dose: | 0.92 |
Skin Sensitization: | 0.234 | Carcinogencity: | 0.246 |
Eye Corrosion: | 0.047 | Eye Irritation: | 0.122 |
Respiratory Toxicity: | 0.398 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002503 | ![]() |
0.636 | D03KXY | ![]() |
0.229 | ||
ENC002498 | ![]() |
0.636 | D0Z4EI | ![]() |
0.228 | ||
ENC002454 | ![]() |
0.491 | D0CL9S | ![]() |
0.225 | ||
ENC001433 | ![]() |
0.386 | D0WE3O | ![]() |
0.217 | ||
ENC001867 | ![]() |
0.362 | D0X5XU | ![]() |
0.214 | ||
ENC003403 | ![]() |
0.362 | D0R2KF | ![]() |
0.211 | ||
ENC003402 | ![]() |
0.362 | D07XSN | ![]() |
0.208 | ||
ENC002040 | ![]() |
0.351 | D0Y7DP | ![]() |
0.208 | ||
ENC003241 | ![]() |
0.349 | D0TS1Z | ![]() |
0.208 | ||
ENC005864 | ![]() |
0.349 | D09PZO | ![]() |
0.208 |